HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
$2.20
Makalipas ang Oras ng Trabaho:(2.27%)+0.050
$2.25
Sarado: Dis 4, 8:00:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.21
Sakop ng araw
$2.16 - $2.24
Sakop ng taon
$1.64 - $9.30
Market cap
873.33M USD
Average na Volume
16.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 67.46M | 15.20% |
Gastos sa pagpapatakbo | 118.74M | 2.27% |
Net na kita | -91.25M | -9.23% |
Net profit margin | -135.28 | 5.18% |
Kita sa bawat share | -0.25 | 10.71% |
EBITDA | -81.00M | 0.62% |
Aktuwal na % ng binabayarang buwis | 2.57% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 300.80M | -24.32% |
Kabuuang asset | 904.95M | -8.69% |
Kabuuang sagutin | 202.66M | -6.89% |
Kabuuang equity | 702.29M | — |
Natitirang share | 396.97M | — |
Presyo para makapag-book | 1.21 | — |
Return on assets | -24.76% | — |
Return on capital | -29.79% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -91.25M | -9.23% |
Cash mula sa mga operasyon | -78.70M | -33.45% |
Cash mula sa pag-invest | 17.01M | 134.86% |
Cash mula sa financing | 88.06M | 109.89% |
Net change in cash | 25.69M | 139.78% |
Malayang cash flow | -52.92M | -121.55% |
Tungkol
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
838
